Biology subjects

Windbergs, M.

Publications and source records attributed to Windbergs, M..

5 recordsLinked to original sources

bioRxiv2026

Cathepsin-dependent amyloid formation drives mechanical rupture of lysosomal membranes

Lysosomal membrane integrity is essential for cellular homeostasis, and its failure drives lysosomal storage disorders (LSD) and neurodegeneration. The dipeptide L-leucyl-L-leucine methyl ester (LLOMe) is widely used to model lysosomal damage, yet its mechanism remains poorly understood. The prevailing view holds that LLOMe polymerizes into membrane-permeabilizing peptide chains within the lysosomal lumen. Using cryo-electron tomography in cultured cells and primary neurons, we visualized the structural basis of LLOMe-induced lysosomal damage. We reveal that LLOMe forms amyloid structures within lysosomes that directly interact with and rupture the limiting membrane through mechanical stress. In vitro reconstitution confirms this amyloid-mediated mechanism. These findings establish a structural paradigm for lysosomal membrane disruption and provide insights into how disease-relevant protein aggregates, implicated in neurodegeneration and LSD, may compromise lysosomal integrity.

cell biology↗

bioRxiv2025

Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology

Microglia are highly plastic cells that are capable of integrating subsequent insults. As the majority of Alzheimers Disease (AD) patients also show cerebrovascular pathology, we here aimed to dissect the interactions between AD and ischemic brain injury on the microglial response to amyloid beta (A{beta}) pathology. Surprisingly, we find that ischemic stroke in the presence of cerebral {beta}-amyloidosis results in the generation of a novel neuroprotective microglial phenotype. These microglia drive a rapid accumulation of highly dense A{beta} plaques that exhibit a relatively benign nature and are strikingly similar to A{beta} plaques observed in patients that are resilient to AD pathology. Thus, our data do not only highlight the impact of a co-morbid state of brain ischemia and A{beta} pathology on the microglial phenotype but also identify novel molecular pathways that may serve to promote beneficial microglial functions in AD.

neuroscience↗

bioRxiv2025

Raman spectroscopy reveals growth phase-dependent molecular differences in bacterial membrane vesicles

Bacterial membrane vesicles (BMVs) have attracted significant attention as highly efficient transport vehicles for molecules crossing biological barriers and as key mediators in infection processes. As interest in BMVs increases, the need for standardized isolation protocols and comprehensive analytical approaches becomes apparent. This study introduces Raman spectroscopy as a novel, chemically selective monitoring approach for the analysis of subtle biochemical changes in BMVs across different bacterial growth phases. BMVs derived from Pseudomonas aeruginosa, a Gram-negative human pathogen responsible for severe nosocomial infections, were isolated at six different time points and analyzed via established physicochemical and functional assays, as well as Raman spectroscopy. While established analytics revealed growth phase-dependent variations in protein content, surface charge, and immunogenic effects on human immune cells, Raman spectroscopy enabled the comprehensive analysis of molecular-level changes between isolation time points. Significant shifts in protein-to-lipid ratios, higher lipid saturation, and changes in protein secondary structure were detected in BMVs isolated from later growth phases. Further, the absence of spectral markers for nucleic acids enabled the identification of BMVs as outer membrane vesicles. These findings emphasize the critical influence of the isolation time point on BMV properties and highlight Raman spectroscopy as a powerful tool for semi-quantitative chemical profiling, revealing minuscule yet biologically significant changes in BMVs depending on isolation time points.

cell biology↗

bioRxiv2024

A hybrid bioprinting-electrospinning platform integrating nanofibers and mesenchymal cell spheroids for customizable wound healing dressings

We introduce a platform for the fabrication of customizable wound healing dressing. The platform integrates electrospun nanofibers, bioprinted hydrogels, and cellular spheroids into hierarchical, fiber-reinforced hybrid constructs. The construct leverages the mechanical strength of polycaprolactone (PCL) nanofibers and the ECM-like properties of GelMA/PEGDA hydrogel. These materials support the incorporation of bone marrow-derived mesenchymal stem cell (BM-hMSC) spheroids, which act as a supportive "cell niche," enhancing the viability of the hMSC during and after bioprinting, and facilitating their spreading across the construct during the maturation phase. The characterization of the hybrid constructs demonstrated strong structural integrity and enhanced mechanical properties, making them well-suited for clinical wound dressing applications. In vitro assays, including live/dead staining, MTT assays, and scratch assays, revealed increased cell attachment, proliferation, and migration. The spheroids maintained their viability over extended periods, significantly contributing to wound closure in the scratch assay. This innovative approach, which combines electrospinning and light-based bioprinting, offers a promising strategy for the development of customizable wound dressings that closely adapt to the complex architecture of human skin. The bioprinting approach allows for the creation of tailored geometries for specific clinical requirements. Future research will focus on optimizing scaffold design and conducting long-term in vivo studies to validate the platforms clinical potential.

cell biology↗

bioRxiv2024

Predicting nanocarrier permeation across the human intestine in vitro: Model matters

For clinical translation of oral nanocarriers, simulation of the complex intestinal microenvironment is crucial to evaluate interactions and transport across the intestinal mucosa for predicting the drugs bioavailability. However, permeation studies are often conducted using simplistic cell culture models, overlooking key physiological factors such as tissue composition, morphology, and additional diffusion barriers as constituted by mucus. This oversight may potentially lead to an incomplete evaluation of the nanocarrier-tissue interactions and an overestimation of permeation. In this study, we systematically investigated different 3D tissue models of the human intestine under static cultivation and dynamic flow conditions with respect to tissue morphology, mucus production, and their impact on nanocarrier permeation. Our results revealed that the cell ratio between the different cell types (enterocytes and goblet cells), as well as the choice of culture conditions, had a notable impact on tissue layer thickness, mucus secretion, and barrier impairment, all of which were increased under dynamic flow conditions. Permeation studies with polymeric nanocarriers (PLGA and PEG-PLGA) elucidated that the amount of mucus present in the respective model was the limiting factor for the permeation of PLGA nanocarriers, while tissue topography represented the key factor influencing PEG-PLGA nanocarrier permeation. Furthermore, both nanocarriers exhibited diametrically opposite permeation kinetics in a direct comparison to soluble compounds. In summary, these findings reveal the critical role of the implemented test systems on permeation assessment and emphasize that, in the context of preclinical nanocarrier testing, the choice of in vitro model matters.

pharmacology and toxicology↗